Teva Pharma - TEVA Total Company Value

Brandmark of Teva Pharmaceutical Industries Limited (TEVA)

Teva Pharmaceutical Industries (TEVA) focuses its R&D strategy on developing biosimilars and enhancing complex generics. This chart on the GURU.Markets platform reflects a business valuation of 62270.48, supported by a robust international network of manufacturing plants in Europe and Israel. Stable demand for medications makes the company resilient to economic shocks, providing defensive qualities for investments regardless of the market cycle.

TEVA Teva Pharmaceutical Industries Ltd.: Total Company Value in the range 11/23/2025 - 11/01/2026

Teva Pharma (TEVA) - metric breakdowns and financial figures

- market value and analyst target forecast:
Market Price Teva Pharmaceuticals|TEVA - Consensus Target
- issuer market value details:
Market Value Teva|TEVA - Enterprise Value
- business book valuation details:
Book Value per Share Teva|TEVA - Company Book Value|Market Capitalization to Net Assets tevapharm.com|TEVA - Company Total Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Teva Pharmaceutical Industries|TEVA - Long-Term Debt to Capital|Short-Term Debt to Capital Teva Pharmaceutical Industries Ltd.|TEVA - Company Debts|Debt to Net Assets Ratio Teva|TEVA - Company Long-Term Debt|Company Current Liabilities Teva|Quick Ratio tevapharm.com
- business earnings and investment ratios data:
TEVA - Net Income
Analysis of all company metrics:tevapharm.com
Brand item of Teva Pharma

Enterprise value combines market capitalization and net debt, determining the total acquisition price of the business for a potential owner. Analyzing the market price of Teva Pharmaceutical Industries (TEVA) while accounting for cash and debt allows for an assessment of the effectiveness of Richard Francis's strategy to reduce borrowings and legal liabilities as Teva Pharmaceutical Industries (TEVA) transitions from traditional generics to high-margin innovative drugs.

Competitors of Teva Pharmaceutical Industries (TEVA)

Lilly (LLY) - Total Enterprise Value|ABBV: Real Price to Acquire Entire Company|AZN: Total Company Value|NVS: Enterprise Value|merck.com (MRK) - Enterprise Value|Total Company Value Novo Nordisk|Amgen Corp - Full Business Value|Enterprise Value PFE|SNY (Sanofi Group) - Value Adjusted for Debt and Cash|Enterprise Value BMY (Bristol-Myers Squibb)|Enterprise Value GlaxoSmithKline plc GSK|TAK - Total Company Value|Value Adjusted for Debt and Cash RDY (Dr. Reddy's Laboratories Limited)|Viatris Corp (VTRS) - Total Company Value|Real Price to Acquire Entire Company Roivant Corp|ZLAB (Zai Lab Limited) - Enterprise Value|Enterprise Value bauschhealth.com|Real Price to Acquire Entire Company COSM (Cosmos Health)